Xoma | XOMA - Assets

Stock Price
25.81
Daily Change
1.41 5.78%
Monthly
-5.35%
Yearly
9.74%
Q1 Forecast
25.01

Xoma reported $263.15M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.96B 62M Dec/2025
Agenus USD 233.89M 48.67M Sep/2025
Agios Pharmaceuticals USD 1.3B 88.48M Dec/2025
Ardelyx USD 486.17M 19.4M Sep/2025
aTyr Pharma USD 106.65M 5.12M Sep/2025
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Celldex Therapeutics USD 648.44M 43.97M Sep/2025
Curis USD 29.23M 10.09M Jun/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Emergent BioSolutions USD 1.82B 69.9M Dec/2023
Incyte USD 6.96B 627.62M Dec/2025
MacroGenics USD 270.76M 25.34M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Prothena USD 352.63M 46.44M Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Xoma USD 263.15M 39.7M Sep/2025